News And Events

New research published in the American Journal of Psychiatry provides further evidence of the effectiveness of Early Psychosis treatments pioneered at Orygen in Australia. The US-based RAISE study, which was funded by the National Institute of Mental Health and inspired by over two decades of research at Orygen and our partners around the world, has shown that comprehensive care for first-episode psychosis improves both functional and clinical outcomes.

While there is significant global evidence of the effectiveness of Early Psychosis programs, this is first major multi-site trial conducted in the United States. An Early Psychosis program based on the Early Psychosis Prevention and Intervention Centre (EPPIC), which was pioneered by Professor Patrick McGorry AO and colleagues at Orygen in Melbourne, is being rolled out nationally in Australia through the headspace platform. A number of other countries have adopted Early Psychosis services based on this approach.

Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program